![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/07/shutterstock_2472179159.jpg)
SIGA scores HHS contract for smallpox vaccine Tpoxx worth $113m
The US Department of Health and Human Services (HHS) has exercised a procurement option for SIGA Technologies’ oral Tpoxx (tecovirimat). The contract is worth approximately $113m and builds on the previous procurement agreement with the US HHS for Tpoxx. …